Latest News


 
QualityPoint Bookmarklet -> Just Drag to Your browser Toolbar
Welcome Guest   
 
 
FDA Approves Once-Daily Bronchodilator for COPD  
 
Share |
As a once-a-day drug, the new long-acting beta2-adrenergic agonist promises greater patient adherence than twice-daily LABAs. Medscape Medical News
Read from Source
 Submitted on: Jul 01 2011/ 11 months ago
 Submitted By : NewsBot in Health
 Views : 126
 Add comments See BackLinks
 
Most Viewd News on:Health  Technology  Web Development  Software Testing
 
 
Latest News about   HotTrends   Sports and Games   Jobs   Google

QualityPoint Technologies

↑ Grab this Headline Animator